Deglycosylation of apo B-containing lipoproteins increase their ability to aggregate and to promote intracellular cholesterol accumulation in vitro

References

• A L Bartlett, and K K Stanley. (1998). All low density lipoprotein particles are partially desialylated in plasma. Atherosclerosis 138 (2):237–245.
   PubMed Web of Science ®Google Scholar
• E G Bligh, and W J Dyer. (1959). A rapid method for total lipid extraction and purification. Can J Biochem Physiol 37:911–914.
   PubMedGoogle Scholar
• H Busch, A Hasilik, and W Domschke. (1995). Elevated level of β-hexosaminidase and α-mannosidase in human immunodeficiency virus-infected patients. J Infect Dis 171:683–686.
   PubMed Web of Science ®Google Scholar
• A S Cross, and D G Wrigh. (1991). Mobilization of sialidase from intracellular stores to the surface of human neutrophils and its role in stimulated adhesion responses of these cells. J Clin Invest 88:2067–2076.
   PubMed Web of Science ®Google Scholar
• M Dubois, K A Gilles, J K Hamilton, P A Rebers, and F Smith. (1956). Colorimetric method for determination of sugars and related substances. Anal Chem 28:350–354.
   Web of Science ®Google Scholar
• A Filipovic, G Schwarzmann, W Mraz, H Wiegandt, and E Buddecke. (1979). Sialic acid content of low-density lipoproteins controls their binding and uptake by cultured cells. Eur J Biochem 93:51–55.
   PubMedGoogle Scholar
• Y Fujioka, T Taniguchi, Y Ishikawa, and M Yokoyama. (2000). Significance of acidic sugar chains of apolipoprotein B-100 in cellular metabolism of low-density lipoproteins. J Lab Clin Med 136:355–362.
   PubMed Web of Science ®Google Scholar
• B Garner, D J Harvey, L Royle, M Frischmann, F Nigon, M J Chapman, and P M Rudd. (2001). Characterization of human apolipoprotein B100 oligosaccharides in LDL subfractions derived from normal and hyperlipidemic plasma: deficiency of alpha-N-acetylneuraminyllactosyl-ceramide in light and small dense LDL particles. Glycobiology 11 (10):791–802.
   PubMed Web of Science ®Google Scholar
• N K Golovanova, E V Gracheva, O P Il'inskaya, E M Tararak, and N V Prokazova. (2002). Sialidase activity in normal and atherosclerotic human aortic intima. Biochemistry (Moscow) 67 (11):1230–1234.
   PubMed Web of Science ®Google Scholar
• E V Gracheva, N N Samovilova, N K Golovanova, O P Il'inskaya, E M Tararak, P Malyshev, V V Kukharchuk, and N V Prokazova. (2002). Sialyltransferase activity of human plasma and aortic intima is enhanced in atherosclerosis. Biochim Biophiz Acta 1586 (1):123–128.
   PubMed Web of Science ®Google Scholar
• J K Hakala, K Öörni, M Ala-Korpela, and P T Kovanen. (1999). Lipolytic modification of LDL by phospholipase A2 induces particle aggregation in the absence and fusion in the presence of heparin. Arterioscler Thromb Vasc Biol 19:1276–1283.
   PubMed Web of Science ®Google Scholar
• V A Hanson, U R Schettinger, R R Loungani, and M A Nadijcka. (1987). Plasma sialidase activity in acute myocardial infarction. Am Heart J 114:59–63.
   PubMed Web of Science ®Google Scholar
• A Hara, and N S Radin. (1978). Lipid extraction of tissue with low-toxicity solvent. Anal Biochem 90:420–426.
   PubMed Web of Science ®Google Scholar
• S Hirani, and B Winchester. (1979). The multiple forms of α-D-mannosidase in human plasma. Biochem J 179:583–592.
   PubMed Web of Science ®Google Scholar
• AYa Khorlin, S D Shiyan, V A Markin, V V Nasonov, and M N Mirzyanova. (1986). Fluorescent derivatives of carbohydrates in the structural analysis of glycoconjugates. N-(4-methylcoumarin-7-yl)glucamines: synthesis, characterization, and use in carbohydrate analysis. Bioorgan Khim (Rus) 12:1203–1212.
   Web of Science ®Google Scholar
• M La Belle, and R M Krauss. (1990). Differences in carbohydrate content of low density lipoproteins associated with low density lipoprotein subclass patterns. J Lipid Res 31:1577–1588.
   PubMed Web of Science ®Google Scholar
• A Lombardo, C Bairati, G Goi, C Roggi, L Maccarini, D Bollini, and A Burlina. (1996). Plasma lysosomal glycohydrolases in a general population. Clin Chim Acta 247:39–49.
   PubMed Web of Science ®Google Scholar
• O H Lowry, N J Rosenbrough, A L Farr, and R J Randall. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275.
   PubMed Web of Science ®Google Scholar
• T A Musliner, K M McVicker, J F Iosefa, and R M Krauss. (1987). Lipolysis products promote the formation of complexes of very-low-density and low-density lipoproteins. Biochim Biophys Acta 919:97–110.
   PubMed Web of Science ®Google Scholar
• K Öörni, J K Hakala, A Annila, M Ala-Korpela, and P T Kovanen. (1998). Sphingomyelinase induces aggregation and fusion, but phospholipase A2 only aggregation, of low density lipoprotein particles. J Biol Chem 273 (44):29127–29134.
   PubMed Web of Science ®Google Scholar
• K Öörni, M Pentikäinen, M Ala-Korpela, and P T Kovanen. (2000). Aggregation, fusion, and vesicle formation of modified low density lipoprotein particles: molecular mechanisms and effects on matrix interactions. J Lipid Res 41 (11):1703–1714.
   PubMed Web of Science ®Google Scholar
• K Öörni, P Posio, M Ala-Korpela, M Jauhiainen, and P T Kovanen. (2005). Sphingomyelinase induces aggregation and fusion of small very low-density lipoprotein and intermediate-density lipoprotein particles and increases their retention to human arterial proteoglycans. Arterioscler Thromb Vasc Biol 25 (8):1678–1683.
   PubMed Web of Science ®Google Scholar
• A N Orekhov, V V Tertov, I D Novikov, A V Krushinsky, E R Andreeva, V Z Lankin, and V N Smirnov. (1985). Lipids in cells of atherosclerotic and uninvolved human aorta. I. Lipid composition of aortic tissue and enzyme isolated and cultured cells. Exp Mol Pathol 42:117–137.
   PubMed Web of Science ®Google Scholar
• A N Orekhov, V V Tertov, D N Mukhin, and I A Mikhailenko. (1989). Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells. Discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients. Biochem Biophys Res Commun 162:206–211.
   PubMed Web of Science ®Google Scholar
• A N Orekhov, V V Tertov, and D N Mukhin. (1991). Desialylated low density lipoprotein–naturally occurring lipoprotein with atherogenic potency. Atherosclerosis 86:153–161.
   PubMed Web of Science ®Google Scholar
• A N Orekhov, V V Tertov, I A Sobenin, V N Smirnov, D P Via, J GuevaraJr, A M GottoJr, and J D Morrisett. (1992). Sialic acid content of human low density lipoproteins affects their interaction with cell receptors and intracellular lipid accumulation. J Lipid Res 33:805–807.
   PubMed Web of Science ®Google Scholar
• M Pentikainen, E MP Lehtonen, and P T Kovanen. (1996). Aggregation and fusion of modified low density lipoprotein. J Lipid Res 37:2638–2649.
   PubMed Web of Science ®Google Scholar
• E M Prence, and M R Natowicz. (1992). Diagnosis of α-mannosidosis by measuring α-mannosidase in plasma. Clin Chem 38:501–503.
   PubMed Web of Science ®Google Scholar
• B Rodriguez-Iturbe, V N Katiyar, and J Coello. (1981). Neuraminidase activity and free sialic acid levels in the serum of patients with acute poststreptococcal glomerulonephritis. N Engl J Med 304:1506–1510.
   PubMed Web of Science ®Google Scholar
• J S Shannon, T R Lappin, G E Elder, G M Roberts, M G McGeown, and J M Bridges. (1985). Increased plasma glycosidase and protease activity in uraemia: possible role in the aetiology of the anaemia of chronic renal failure. Clin Chim Acta 153:203–207.
   PubMed Web of Science ®Google Scholar
• I A Sobenin, V V Tertov, and A N Orekhov. (1998). Optimization of the assay for sialic acid determination in low density lipoprotein. J Lipid Res 39:2293–2299.
   PubMed Web of Science ®Google Scholar
• T Suzuki, K Kitajima, S Inoue, and Y Inoue. (1994). Occurrence and biological roles of “proximal glycanases” in animal cells. Glycobiology 4:777–789.
   PubMed Web of Science ®Google Scholar
• T Taniguchi, Y Ishikawa, M Tsunemitsu, and H Fukuzaki. (1989). The structures of asparagines-linked sugar chains of human apolipoprotein B-100. Arch Biochem Biophys 273:197–205.
   PubMed Web of Science ®Google Scholar
• V V Tertov, I A Sobenin, Z A Gabbasov, E G Popov, and A N Orekhov. (1989). Lipoprotein aggregation as an essential condition of intracellular lipid caused by modified low density lipoproteins. Biochem Biophys Res Commun 163:489–493.
   PubMed Web of Science ®Google Scholar
• V V Tertov, I A Sobenin, A G Tonevitsky, A N Orekhov, and V N Smirnov. (1990). Isolation of atherogenic modified (desialylated) low density lipoprotein from blood of atherosclerotic patients: separation from native lipoprotein by affinity chromatography. Biochem Biophys Res Commun 167:1122–1127.
   PubMed Web of Science ®Google Scholar
• V V Tertov, I A Sobenin, Z A Gabbasov, E G Popov, O Jaakkola, T Solakivi, T Nikkari, V N Smirnov, and A N Orekhov. (1992a). Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation: isolation, fractionation and characterization. Lab Invest 67:665–675.
   PubMed Web of Science ®Google Scholar
• V V Tertov, A N Orekhov, I A Sobenin, Z A Gabbasov, E G Popov, A A Yaroslavov, and V N Smirnov. (1992b). Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation due to lipoprotein aggregation. Circ Res 71:218–228.
   PubMed Web of Science ®Google Scholar
• V V Tertov, A N Orekhov, I A Sobenin, J D Morrisetti, A M Gotto, and J G Guevara. (1993). Carbohydrate composition of protein and lipid components in sialic acid-rich and -poor low density lipoptoteins from subjects with and without coronary artery disease. J Lipid Res 34:365–375.
   PubMed Web of Science ®Google Scholar
• V V Tertov, V V Kaplun, S N Dvoryantsev, and A N Orekhov. (1995). Apolipoprotein B-bound lipids as a marker for evaluation of low density lipoprotein oxidation in vivo. Biochem Biophys Res Commun 214:608–613.
   PubMed Web of Science ®Google Scholar
• V V Tertov, V V Kaplun, I A Sobenin, and A N Orekhov. (1998). Low-density lipoprotein modification occurring in human plasma. Possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification. Atherosclerosis 138:183–195.
   PubMed Web of Science ®Google Scholar
• V V Tertov, V V Kaplun, I A Sobenin, E Y Boytsova, N V Bovin, and A N Orekhov. (2001). Human plasma trans-sialidase causes atherogenic modification of low density lipoprotein. Atherosclerosis 159 (1):103–115.
   PubMed Web of Science ®Google Scholar
• M Vauhkonen, J Viitala, J Parkkinen, and H Rauvala. (1985). High-mannose structures of apolipoprotein-B from low density lipoproteins of human plasma. Eur J Biochem 152:43–50.
   PubMedGoogle Scholar
• B Venerando, A Fiorilli, G L Croci, and G Tettamanti. (1997). Presence in human erythrocyte membranes of a novel form of sialidase acting optimally at neutral pH. Blood 90:2047–2056.
   PubMed Web of Science ®Google Scholar
• L Warren. (1959). The thiobarbituric acid assay of sialic acids. J Biol Chem 234:1971–1975.
   PubMed Web of Science ®Google Scholar
• X X Xu, and I Tabas. (1991). Sphingomyelinase enhances low density lipoprotein uptake and ability to induce cholesteryl ester accumulation in macrophages. J Biol Chem 266:24849–24858.
   PubMed Web of Science ®Google Scholar